STOCK TITAN

Marex reports 7.21% stake in AXT Inc

AXT Inc. reported that Marex Securities Products, Inc. and Marex Group plc disclosed beneficial ownership of 4,005,709 shares of common stock, representing 7.21% of the class.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

AXT Inc. reported that Marex Securities Products, Inc. and Marex Group plc disclosed beneficial ownership of 4,005,709 shares of common stock, representing 7.21% of the class. The filing states the reporting entities have sole voting and sole dispositive power over all 4,005,709 shares. The address and CUSIP 00246W103 are included in the filing.

Insights

Marex discloses a passive, material stake of 4,005,709 shares (7.21%).

The filing is a Schedule 13G reporting beneficial ownership with sole voting and dispositive power attributed to Marex entities. This indicates a sizeable passive position reported pursuant to beneficial‑ownership disclosure rules rather than an active takeover filing.

Shareholders may note the 05/01/2026 reporting context and the filing signatures dated 05/06/2026. Subsequent filings could disclose changes in voting or disposition authority.

Reported shares beneficially owned 4,005,709 shares Schedule 13G ownership reported
Percent of class 7.21% Percent of common stock reported
CUSIP 00246W103 AXT Inc Common Stock
Reporting date 05/01/2026 Ownership date shown in filing
Filing signature date 05/06/2026 Dates of signatures by Marex officers
Schedule 13G regulatory
"Name of issuer: AXT INC (Schedule 13G reporting)"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Beneficially owned regulatory
"Amount beneficially owned: 4,005,709"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Sole Dispositive Power regulatory
"Sole Dispositive Power 4,005,709.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake did Marex report in AXT Inc (AXTI)?

Marex reported beneficial ownership of 4,005,709 shares, equal to 7.21% of AXT Inc. This position is disclosed on the Schedule 13G and tied to CUSIP 00246W103.

Which Marex entities filed the Schedule 13G for AXTI?

The filing lists Marex Securities Products, Inc. and Marex Group plc as the reporting persons. Addresses for both entities and their citizenship (Delaware and United Kingdom) are included.

What voting and dispositive powers does Marex claim for AXTI shares?

Marex reports sole voting power of 4,005,709 shares and sole dispositive power of the same number, with no shared voting or dispositive power listed in the filing.

What dates appear in the Schedule 13G for AXTI?

The content shows an ownership date of 05/01/2026 and signatures dated 05/06/2026. These dates provide the reporting timeframe for the disclosed holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Accepted by SEC EDGAR Learn about SEC filing dates





00246W103

(CUSIP Number)
05/01/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Marex Securities Products Inc.
Signature:Jennifer Kaiser
Name/Title:COO
Date:05/06/2026
Marex Group plc
Signature:Scott Linsley
Name/Title:Corporate Secretary
Date:05/06/2026

Keep reading